Hemangioendothelioma — Trials

Hemangioendothelioma — Trials · CancerIndex

Clinical trials

Registered studies

21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03331250	Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)	completed	Phase 2	13	Massachusetts General HospitalOTHER	1	Aug 28, 2026	clinicaltrials
NCT04008238	Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients(PIPER)	completed	N/A	29	Institut BergoniéOTHER	1	Mar 6, 2026	clinicaltrials
NCT02625389	A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures	completed	Phase 4	132	GuerbetINDUSTRY	1	Oct 10, 2025	clinicaltrials
NCT03148275	Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

Data updated 22 days agoSource updated Aug 28, 2026source: clinicaltrials